Align Technology (ALGN) Tops Q2 View; Guides Below
More News related to ALGN
- Align Technology Executive to Present At JPMorgan Healthcare Conference
- Align Technology (ALGN) to Directly Manufacture Custom-Made Clear Aligners Independently
- Align Technology Announces Plans to Assume Operations From Its Manufacturing Services Provider
- Align Technology (ALGN) Receives Regulatory Approval for Invisalign in Japan
- Align Technology Receives Expanded Regulatory Approval in Japan
More News related to Earnings
- Standard & Poor's Lowers Ratings on PNC Financial (PNC)
- DA Davidson Downgrades Cascade (CAE) to Underperform
- BMO Downgrades F5 Networks (FFIV) to Market Perform
- Sterne Agee Downgrades EZCorp (EZPW) to Neutral
- CL King Downgrades Steven Madden (SHOO) to Neutral
Align Technology (Nasdaq: ALGN) reports Q2 EPS of $0.06, 1 cents better than the analyst estimate of $0.05. Revenues for the quarter were $79.9 million, versus the consensus of $79.67 million.
Align Technology sees Q3 EPS of $0.04-$0.06, versus the consensus of $0.11. Sees 2008 EPS of $0.29-$0.33, versus the consensus of $0.40.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
-0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
